A portable electrochemical biosensor platform can combine measurement electronics, a recognition element and wireless data handling in a compact instrument. One developed system demonstrates this approach for hepatitis C virus (HCV) immunodiagnostics, using cyclic voltammetry to measure the response of a functionalized electrode. For automation engineers and system integrators, the work offers a useful example of how sensing hardware, embedded control and a mobile interface can be brought together in a portable analytical device.
How the portable electrochemical biosensor works
The platform is built around a microcontroller, a potentiostat circuit, a Bluetooth module, rechargeable power and microSD storage. A mobile application lets an operator configure a measurement and view results in real time. Data can also be stored locally, so the measurement process does not depend solely on the mobile display.
The potentiostat controls the potential applied to an electrochemical cell and measures the resulting current. The cell uses three electrodes: a working electrode, where the reaction of interest occurs; a reference electrode, which provides a stable potential reference; and a counter electrode, which completes the circuit. The platform generates the test waveform, reads the current response and converts the measurement into data for display or storage.
Its main measurement technique is cyclic voltammetry. In this method, the applied potential sweeps between selected limits in a repeating triangular pattern. As the potential changes, electroactive species at the electrode can undergo oxidation or reduction. The resulting current-versus-potential curve provides information about the electrochemical process and can change when material at the electrode surface alters electron transfer.
Electrode functionalization creates the recognition layer
For the HCV application, the working electrode is modified to recognize a specific antigen–antibody interaction. The sensor’s gold working and counter electrodes are paired with a silver reference electrode. Cystamine and glutaraldehyde are used to support covalent attachment of recombinant core-HCV protein to the working electrode. The protein acts as the recognition element for the corresponding anti-core-HCV IgG antibodies.
The measurement uses a potassium ferrocyanide redox solution in phosphate-buffered saline. When the target antibody binds to the immobilized antigen, the resulting surface changes affect electron transfer between the redox species and the electrode. In the reported tests, this interaction was associated with a reduction in anodic peak current. The platform therefore detects the binding indirectly by measuring an electrochemical change, rather than by identifying the antibody through a visual signal.
Portable potentiostat design and operation
The instrument was designed to be operated through a mobile device while keeping the electrochemical measurement circuitry in a small enclosure. Bluetooth provides two-way communication for configuration and data transfer. The system also includes a microSD card for storing measurement curves, a rechargeable battery and a charging circuit. Its enclosure measures 115 × 75 × 30 mm, and the sensor connects through a plug-and-play interface.
The potentiostat applies a voltage sweep and converts the current generated at the working electrode into a voltage that the microcontroller can acquire. Selectable feedback resistors in the current-to-voltage stage provide measurement ranges of 1 mA, 100 μA, 10 μA and 1 μA. The design supports sweep voltages from −1.5 V to +1.5 V. Measurement settings, including scan rate and cycle count, can be set through the mobile interface.
In calibration tests using reference circuits, the platform’s measurements were compared with those from a commercial potentiostat. The authors report a linear correlation of R² = 0.9999 for the comparison. Tests with the ferrocyanide solution across multiple sensors were also used to assess the platform’s measurement behavior and sensor repeatability. These results concern the reported calibration and test conditions; they should not be interpreted as a substitute for clinical validation.
Interpreting the HCV immunosensor results
The immunosensor was evaluated at several concentrations of anti-core-HCV IgG. The reported response showed a decrease in anodic peak current as antibody concentration increased. A statistically significant difference was observed at 1.0 and 10 ng/μL compared with the negative control, while the 0.1 ng/μL concentration did not show a significant difference from that control. The authors identified 1.0 ng/μL as the immunosensor’s analytical sensitivity under the tested conditions.
This distinction matters when assessing a biosensor prototype. An analytical response in controlled tests demonstrates that the sensor and instrument can register a target-related change; it does not, on its own, establish performance for routine patient testing. The system’s intended value is as a portable diagnostic platform concept, with further development and validation required before drawing conclusions about clinical deployment.
Practical design considerations for portable measurement systems
The platform illustrates several design decisions relevant to compact instrumentation:
- Measurement integrity: The potentiostat must control electrode potential while accurately converting small electrochemical currents into a signal the controller can read.
- Sensor interface: A replaceable, plug-and-play electrode helps separate the sensing element from the reusable electronics.
- Data handling: Wireless display and onboard storage serve different needs: immediate operator feedback and retention of measurement records.
- Power budget: The reported power consumption is 280.5 mW at 3.3 V in the stated Bluetooth-enabled operating case, with an average battery life of 195 minutes.
- Usability: A mobile interface and compact enclosure support operation outside a conventional benchtop setup, while still allowing configurable test parameters.
These considerations are familiar across embedded measurement and automation projects, even though this particular platform is intended for electrochemical diagnostics rather than industrial process control. Portable instruments must balance analog measurement performance, communications, power consumption, data storage and operator workflow within a constrained package.
Conclusion
This portable electrochemical biosensor combines a custom potentiostat, cyclic voltammetry, a functionalized immunosensor and mobile-device communication in a compact laboratory platform. Its reported tests demonstrate measurement agreement with a commercial instrument under calibration conditions and an antibody-dependent response from the HCV sensor. For technical decision-makers, the key lesson is architectural: dependable portable analysis depends on the coordinated design of the electrochemical interface, signal-conditioning electronics, embedded control, power system and data workflow. The prototype provides a foundation for further research, not a claim of established clinical readiness.